Ex vivo editing of human hematopoietic stem cells for erythroid expression of therapeutic proteins

A platform for systemic therapeutic transgene expression independent of patient mutations needs a safe and highly transcribed locus. Here the authors ex vivo edit HPSCs using CRISPR-Cas9 to integrate transgenes under the α-globin promoter to achieve erythroid specific expression.

Guardado en:
Detalles Bibliográficos
Autores principales: Giulia Pavani, Marine Laurent, Anna Fabiano, Erika Cantelli, Aboud Sakkal, Guillaume Corre, Peter J. Lenting, Jean-Paul Concordet, Magali Toueille, Annarita Miccio, Mario Amendola
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2020
Materias:
Q
Acceso en línea:https://doaj.org/article/bd6f18164a234100805135163a84adaa
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:bd6f18164a234100805135163a84adaa
record_format dspace
spelling oai:doaj.org-article:bd6f18164a234100805135163a84adaa2021-12-02T16:30:12ZEx vivo editing of human hematopoietic stem cells for erythroid expression of therapeutic proteins10.1038/s41467-020-17552-32041-1723https://doaj.org/article/bd6f18164a234100805135163a84adaa2020-07-01T00:00:00Zhttps://doi.org/10.1038/s41467-020-17552-3https://doaj.org/toc/2041-1723A platform for systemic therapeutic transgene expression independent of patient mutations needs a safe and highly transcribed locus. Here the authors ex vivo edit HPSCs using CRISPR-Cas9 to integrate transgenes under the α-globin promoter to achieve erythroid specific expression.Giulia PavaniMarine LaurentAnna FabianoErika CantelliAboud SakkalGuillaume CorrePeter J. LentingJean-Paul ConcordetMagali ToueilleAnnarita MiccioMario AmendolaNature PortfolioarticleScienceQENNature Communications, Vol 11, Iss 1, Pp 1-13 (2020)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Giulia Pavani
Marine Laurent
Anna Fabiano
Erika Cantelli
Aboud Sakkal
Guillaume Corre
Peter J. Lenting
Jean-Paul Concordet
Magali Toueille
Annarita Miccio
Mario Amendola
Ex vivo editing of human hematopoietic stem cells for erythroid expression of therapeutic proteins
description A platform for systemic therapeutic transgene expression independent of patient mutations needs a safe and highly transcribed locus. Here the authors ex vivo edit HPSCs using CRISPR-Cas9 to integrate transgenes under the α-globin promoter to achieve erythroid specific expression.
format article
author Giulia Pavani
Marine Laurent
Anna Fabiano
Erika Cantelli
Aboud Sakkal
Guillaume Corre
Peter J. Lenting
Jean-Paul Concordet
Magali Toueille
Annarita Miccio
Mario Amendola
author_facet Giulia Pavani
Marine Laurent
Anna Fabiano
Erika Cantelli
Aboud Sakkal
Guillaume Corre
Peter J. Lenting
Jean-Paul Concordet
Magali Toueille
Annarita Miccio
Mario Amendola
author_sort Giulia Pavani
title Ex vivo editing of human hematopoietic stem cells for erythroid expression of therapeutic proteins
title_short Ex vivo editing of human hematopoietic stem cells for erythroid expression of therapeutic proteins
title_full Ex vivo editing of human hematopoietic stem cells for erythroid expression of therapeutic proteins
title_fullStr Ex vivo editing of human hematopoietic stem cells for erythroid expression of therapeutic proteins
title_full_unstemmed Ex vivo editing of human hematopoietic stem cells for erythroid expression of therapeutic proteins
title_sort ex vivo editing of human hematopoietic stem cells for erythroid expression of therapeutic proteins
publisher Nature Portfolio
publishDate 2020
url https://doaj.org/article/bd6f18164a234100805135163a84adaa
work_keys_str_mv AT giuliapavani exvivoeditingofhumanhematopoieticstemcellsforerythroidexpressionoftherapeuticproteins
AT marinelaurent exvivoeditingofhumanhematopoieticstemcellsforerythroidexpressionoftherapeuticproteins
AT annafabiano exvivoeditingofhumanhematopoieticstemcellsforerythroidexpressionoftherapeuticproteins
AT erikacantelli exvivoeditingofhumanhematopoieticstemcellsforerythroidexpressionoftherapeuticproteins
AT aboudsakkal exvivoeditingofhumanhematopoieticstemcellsforerythroidexpressionoftherapeuticproteins
AT guillaumecorre exvivoeditingofhumanhematopoieticstemcellsforerythroidexpressionoftherapeuticproteins
AT peterjlenting exvivoeditingofhumanhematopoieticstemcellsforerythroidexpressionoftherapeuticproteins
AT jeanpaulconcordet exvivoeditingofhumanhematopoieticstemcellsforerythroidexpressionoftherapeuticproteins
AT magalitoueille exvivoeditingofhumanhematopoieticstemcellsforerythroidexpressionoftherapeuticproteins
AT annaritamiccio exvivoeditingofhumanhematopoieticstemcellsforerythroidexpressionoftherapeuticproteins
AT marioamendola exvivoeditingofhumanhematopoieticstemcellsforerythroidexpressionoftherapeuticproteins
_version_ 1718383955571376128